申请人:Takeda Chemical Industries, Ltd.
公开号:US06211215B1
公开(公告)日:2001-04-03
Heterocyclic compounds represented by the general formula (I)
wherein R stands for an optionally substituted aromatic heterocyclic group;
X stands for oxygen atom, an optionally oxidated sulfur atom, —C(═O)— or —CH(OH)—;
Y stands for CH or N;
m denotes an integer of 0 to 10:
n denotes an integer of 1 to 5:
cyclic group
stands for an optionally substituted aromatic azole group; and
ring A is optionally further substituted,
or salts thereof. The compound (I) possesses action of inhibiting tyrosine kinase and useful as antitumor agents.
通式(I)代表的杂环化合物,其中R代表一个可选择取代的芳香杂环基团;X代表氧原子,一个可选择氧化的硫原子,—C(═O)—或—CH(OH)—;Y代表CH或N;m表示0到10的整数;n表示1到5的整数;环状基团代表一个可选择取代的芳香唑基团;环A可以是可选择进一步取代的,或其盐。化合物(I)具有抑制酪氨酸激酶的作用,并可用作抗肿瘤剂。